Bekanntmachung • Apr 04
Ontex Group NV, Annual General Meeting, May 05, 2026 Ontex Group NV, Annual General Meeting, May 05, 2026, at 14:00 Romance Standard Time. Location: at the company`s headquarters, located at korte keppestraat 21, 9320 aalst in, Belgium Valuation Update With 7 Day Price Move • Mar 30
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to €3.55, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 16x in the Personal Products industry in Europe. Total loss to shareholders of 47% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €6.45 per share. Reported Earnings • Mar 20
Full year 2025 earnings released: EPS: €0.21 (vs €0.26 in FY 2024) Full year 2025 results: EPS: €0.21 (down from €0.26 in FY 2024). Revenue: €1.76b (down 5.3% from FY 2024). Net income: €16.6m (down 21% from FY 2024). Profit margin: 0.9% (down from 1.1% in FY 2024). Revenue is forecast to grow 1.7% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings. Reported Earnings • Feb 13
Full year 2025 earnings released: EPS: €0.21 (vs €0.26 in FY 2024) Full year 2025 results: EPS: €0.21 (down from €0.26 in FY 2024). Revenue: €1.76b (down 5.3% from FY 2024). Net income: €16.6m (down 21% from FY 2024). Profit margin: 0.9% (down from 1.1% in FY 2024). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 1.8% p.a. on average during the next 3 years, compared to a 3.0% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has fallen by 13% per year, which means it is significantly lagging earnings. Bekanntmachung • Feb 06
Ontex Group NV Launches Sensitive Range to Support Better Skin Health in Incontinence Care Ontex Group NV introduced a new adult incontinence range developed to offer superior protection while being gentle on the skin. The first products -Sensitive Pants, Sensitive Slip and Sensitive Form - will become gradually available for healthcare institutions across Europe. Recent European research conducted by Ontex among more than 2,500 people living with incontinence shows that dermatitis and skin irritation remain widespread and have a meaningful impact on daily life. Almost 1 in 2 people living with incontinence have experienced dermatitis or skin irritation in the intimate area; with many describing significant discomfort and effects on confidence and wellbeing. Despite this high prevalence, These findings underline the urgent need for affordable, qualitative incontinence products that actively support skin health. The new Sensitive range has been developed precisely to answer this need--combining trusted protection with dermatological care to help prevent irritation and keep skin as healthy as possible. To address the educational need, the Sensitive range is complemented with expert training advise on how to recognize, prevent and treat dermatitis related to incontinence. This is offered both through Ontex's network of nurse advisors and through the online training platform Ontex Academy. Sensitive range: powerful protection that respects the skin. The new Sensitive range combines proven incontinence protection with dermatological care. Sensitive Pants offer: Topsheet enriched with botanical ingredients - helps to prevent skin irritation; Innovative Y-core technology - for instant dryness; Faster absorption - up to 2.5x faster than previous iD or Serenity pants; Hypoallergenic design - gentle on fragile skin; Odour control technology - for lasting freshness and confidence. Bekanntmachung • Jan 22
Ontex Group Nv Launches Multi-Liquid Liner in Europe, Empowering Women in Perimenopause and Menopause Ontex Group NV announced the commercial launch of its multi-liquid liner, now available on shelf at a leading German retailer, with further rollouts planned across Europe in the coming weeks. The launch builds on strong consumer validation following recent tests, with more than 90% of participating women confirming they would recommend Ontex's multi-liquid liner and buy it again. The multi-liquid liner addresses the evolving needs of women in all life stage, offering reliable protection for menstrual flow, light bladder leaks, and daily vaginal discharges--all in one discreet, comfortable solution. Research confirms that liners are widely used by women for menstruation and daily discharges. An important unmet need is protection against light bladder weakness. The liner is specifically designed to address these needs, often related to perimenopause or menopause. Approved as a medical device, the liner features up to 8 hours leak protection and odour control, and is available in three sizes: regular, large, and extra large. Bekanntmachung • Jan 13
Ontex Group NV Appoints Lorenzo Grabau to the Board Ontex Group NV announced that to strengthen the Board following the resignation of Mr. Jesper Hojer, the Board has co-opted Mr. Lorenzo Grabau as a non-executive director and will submit his ratification at the next shareholders’ meeting. Mr. Grabau brings extensive capital markets and strategic transformation expertise that will be invaluable as Ontex continues to execute its strategic and value creation agenda. Mr. Grabau has considerable experience as director and chair of, and senior advisor to, various listed and non-listed companies. He served as President and CEO of Kinnevik AB. Prior to that, he was a Partner at Goldman Sachs. New Risk • Dec 11
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Austrian stocks, typically moving 3.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (3.3% average weekly change). Minor Risks High level of debt (51% net debt to equity). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.4% net profit margin). Valuation Update With 7 Day Price Move • Dec 11
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to €5.24, the stock trades at a trailing P/E ratio of 54.8x. Average forward P/E is 16x in the Personal Products industry in Europe. Total loss to shareholders of 19% over the past three years. Bekanntmachung • Nov 26
Ontex Group NV Launches Dreamshield®? 360 Night Pants Concept with Extra Addition for Long Night Pants - Driving Growth in the Baby Pants Segment Ontex Group NV announced the launch of Dreamshield®? 360 Night Pants, a new night-time concept designed to give babies dry nights and parents greater peace of mind. The new night pants offer extra absorbency for up to 12 hours of protection - especially important for long nights, heavy wetters, extended naps and travel. Ontex's Dreamshield®?360 baby pants are already trusted for nighttime use, and the new night pants build on that foundation by offering parents an even more reassuring solution for prolonged overnight protection. Research confirms that nighttime performance remains a critical priority for families: 75% of parents identify their baby's sleep quality as their top stressor, with nighttime leaks the leading cause of disruption. Parents increasingly look for products that guarantee dryness for longer periods, not just overnight but also during situations that require absorbency designed for high-demand occasions. Recent consumer insights confirm the relevance of stronger night-time protection: parents choose baby pants more often for nighttime across all ages and tend to switch to baby pants sooner at night than during the day. Dreamshield®? 360 Night pants deliver enhanced overnight performance together with the trusted features of the Dreamshield®? 360 Pants range: Extra absorbency for long nights - up to 12 hours of leak-free sleep and extended-use protection; Triple leak protection - including Ontex's unique urine & poo back barrier; Soft, secure 360deg fit - gentle materials and an elastic waistband for comfortable sleeping; Night-time packaging - clear extra absorbency claims and strong night icons for quick and confident shopper navigation; Sustainability at the core - supporting Ontex's targets of CO2 emissions and plastic reduction across its product portfolio. Bekanntmachung • Oct 30
Ontex Group NV Maintains Earnings Guidance for Full Year 2025 Ontex Group NV maintained earnings guidance for full year 2025. For the year, the company expects revenue to reduce by low single digit like for like. New Risk • Aug 03
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 0.4% Last year net profit margin: 1.9% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks High level of debt (51% net debt to equity). Share price has been volatile over the past 3 months (4.7% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.4% net profit margin). New Risk • Jun 20
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Austrian stocks, typically moving 5.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (60% net debt to equity). Share price has been volatile over the past 3 months (5.8% average weekly change). Large one-off items impacting financial results. Board Change • Jun 11
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 2 highly experienced directors. 2 independent directors (4 non-independent directors). Independent Chairman of the Board Hans Van Bylen was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • May 12
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 2 highly experienced directors. Non-Executive Director Ebrahim Attarzadeh was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Bekanntmachung • Apr 30
Ontex Group NV to Report Q4, 2025 Results on Feb 12, 2026 Ontex Group NV announced that they will report Q4, 2025 results on Feb 12, 2026 Reported Earnings • Mar 22
Full year 2024 earnings released: EPS: €0.26 (vs €0.33 in FY 2023) Full year 2024 results: EPS: €0.26 (down from €0.33 in FY 2023). Revenue: €1.86b (up 3.7% from FY 2023). Net income: €21.0m (down 22% from FY 2023). Profit margin: 1.1% (down from 1.5% in FY 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Board Change • Mar 07
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. Non-Executive Director Ebrahim Attarzadeh was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Feb 21
Full year 2024 earnings released: EPS: €0.26 (vs €0.33 in FY 2023) Full year 2024 results: EPS: €0.26 (down from €0.33 in FY 2023). Revenue: €1.86b (up 3.7% from FY 2023). Net income: €21.0m (down 22% from FY 2023). Profit margin: 1.1% (down from 1.5% in FY 2023). Revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Bekanntmachung • Feb 21
Ontex Group Nv Provides Earnings Guidance for the Year 2025 Ontex Group NV provided earnings guidance for the year 2025. For the year, the company expected revenue to grow by 3% to 5% like for like, supported by double-digit volume growth in North America. Board Change • Feb 19
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. Non-Executive Director Ebrahim Attarzadeh was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Bekanntmachung • Feb 17
Ontex Group NV Introduces Dreamshields Technology in Baby Diapers Across Europe Ontex Group NV announced the commercial launch of its Dreamshields technology for baby diapers. Offering superior performance, all-round leakage protection, and enhanced comfort, Dreamshields ensures optimal dryness while prioritizing sustainability. The Dreamshields technology is now available on shelf in several European markets in Europe, and being rolled out to more customers soon. Dreamshields technology integrates a range of advanced features that benefit both parents and babies, enhancing comfort, Dreamshields, protection, and ease of use. Consumers have responded positively to the innovative technologies. Panel scores show Dreamshields® performs great, especially when it comes to leakage protection. These innovations address both the needs of babies for comfort and the expectations of parents for reliability and sustainability: Unique channel design with gender-specific zones: enhances fast liquid flow across the entire core for superior absorption, ensuring babies stay dry and comfortable; SeconDRY® system: provides instant dryness by rapidly drawing moisture away from the skin, minimizing the risk of irritation; Double-layer core with dual SAP (Super Absorbent Polymer): features two types of SAP, optimizing fast liquid attraction and solid retention for a lighter, more flexible diaper; 360deg protection: combines front and back barriers with anti-leak cuffs, effectively preventing leaks and blow-outs in all directions; Heat release feature: promotes air circulation, maintaining fresh and healthy skin conditions to prevent comfort and rashes; High waist fit: offers a snug and stretchy fit that adapts to baby's movements, ensuring comfort at all times. Board Change • Jan 21
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. Non-Executive Director Ebrahim Attarzadeh was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Bekanntmachung • Oct 24
Ontex Group NV to Report Q3, 2025 Results on Oct 30, 2025 Ontex Group NV announced that they will report Q3, 2025 results on Oct 30, 2025 Bekanntmachung • Aug 29
Ontex Group NV Brings Its Dreamshield® 360o Technology in Baby Pants to Market Across Europe Ontex Group NV announced the commercial launch of its newest baby pants, featuring its Dreamshield® 360o innovation. The Dreamshield® 360deg technology - designed with a unique urine & poo back barrier and a 360 fit for all-around protection and comfort - is available in-stores in Germany. The launch will soon expand to other markets as production ramps up across Ontex plants. Consumer preference confirmed by consumer panel testing: Dreamshield® 360º pants have demonstrated superior performance in multiple consumer panels versus competitor products. Consumers have expressed their preference for Dreamshield® 360º, particularly related to absorption capacity, absence of leaks, dryness and fit. In a recent French study, 65% of consumers considered absorption capacity in baby products to be extremely important, while 55% emphasized the need to keep skin dry, and 62% rated comfort as a crucial factor. Dreamshield® 360º excelled in panels against competitors in all these areas, making it a trusted choice among both parents and retailers. The new range of baby pants features triple leakage barriers and continues to use Ontex’s patented SeconDRY® technology, ensuring all-around anti-leak fit and ultimate dryness. Strong market demand for baby pants: Ontex saw strong growth in its baby pants sales last year and this trend continues in 2024. The rollout of the baby pant technology has started in Europe with room for expansion to other regions. The production follows the demand of retailers across Europe, who saw the results of Dreamshield® 360º in the German consumer panel1 and see how their consumers shift to baby pants over traditional diapers, both in Europe and North America. Lab and panel test by independent Hytec lab in Germany, fourth quarter 2023. Bekanntmachung • Jul 23
Ontex Group NV Announces the Launch of Enhanced Youth Pants This Fall Ontex Group NV announced the launch of enhanced youth pants this fall. The pants are designed to reduce the psychological impact of incontinence during adolescence, offering protection and discretion. The new Ontex youth pants are tailored for children aged 3 to 15 who struggle with bladder control at night, despite staying dry during the day, or have some disability leading to loss of bladder control. The pants are produced by Ontex plants using its growing HappyFit product platform and will be available through retailers and Ontex's online sales channels in Europe, with room for expansion to other regions. The pants are constructed combining absorbent materials for heavy bedwetting protection, a chassis with soft and quiet materials for discretion that also offers an improved fit. The production will also have a significantly lower impact on the environment vs previous concepts. During the production, waste is also minimized. Bekanntmachung • Jun 15
Ontex Group NV Announces Intention to Restructure Its Production and Distribution Activities in Belgium Ontex Group NV announced the intention to restructure its Belgian production and distribution activities, as part of its strategic transformation to strengthen its competitive position in the European market. This intended restructuring would entail the closure of the Eeklo site, as well as the transformation of the Buggenhout site into a Center of Excellence for research, development and production of medium & heavy incontinence care products, enabled by investments in the range of €40 million. The intended restructuring would lead to the reduction of 489 employees in Eeklo and Buggenhout, bringing the total workforce in Belgium to 569 positions, spread over the Buggenhout and Aalst sites. In response to the increasingly competitive personal care market, Ontex is implementing its global transformation plan to strengthen its competitiveness, with a strong focus on customer-centricity, sustainable innovation and organizational and operational cost-efficiency. Since the launch of the transformation plan, numerous initiatives have been implemented, enabling the Group to improve its financial results. These early results provide confidence to pursue the structural transformation to regain and strengthen competitiveness. The intended optimization of Ontex’s Belgian production and distribution activities is an essential strategic initiative aimed at strengthening Ontex’s operational cost-efficiency across Europe. Consequently, Ontex announced its intention to transform its Belgian operations footprint by exiting the Eeklo site and transforming the Buggenhout site into a center of excellence for medium and heavy incontinence products. The intended closure of the Eeklo site would have an impact on all current 349 production-related employees, and the intended reorganization of the Buggenhout site would impact 140 out of 528 employees. Today, the works councils in Eeklo and Buggenhout were informed in line with the legal information and consultation procedure. If – following consultation with the works councils - the intention would be confirmed, the legal procedure would be followed and Ontex would do its utmost best to offer support to all employees involved. In Belgium, Ontex would continue to employ 569 employees, based in Buggenhout and Aalst. Bekanntmachung • May 25
Ontex Group NV Launches Stop&Lock Anti-Leak Technology for Enhanced Baby Comfort and Protection Ontex Group NV announced the introduction of its innovative Stop&Lock Anti-Leak technology in baby care. The Ontex innovation entails the introduction of front and back barriers in newborn and mini sizes of baby diapers, which Ontex produces for retailer partners. Ontex Stop&Lock Anti-Leak technology has been successfully introduced in selected baby diapers in North America and will be launched at a major European retailer in June. Along with leg barriers, Stop&Lock Anti-Leak technology provides 360-degree leakage protection to contain poo explosions, a common issue with newborns fed on breastmilk or formula. This enhances baby comfort and eases parental concerns about major leaks, an important consumer motivator according to research. A 2024 panel test in Europe indicates that 20% of parents surveyed expressed concern about these significant diaper leaks, with many reporting that leaks disrupt outings, as well as their baby’s sleep and play. In response, Ontex front & back barriers ensure 4-side leak protection from both urine and liquid stool. This feature of Ontex Stop&Lock Anti-Leak technology is designed to significantly reduce the need for frequent and complete outfit changes due to leakage incidents. New Risk • May 08
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Austrian stocks, typically moving 4.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.2x net interest cover). Minor Risks Share price has been volatile over the past 3 months (4.6% average weekly change). Large one-off items impacting financial results. Bekanntmachung • May 03
Ontex Group NV Provides Earnings Guidance for the Year 2024 Ontex Group NV provided earnings guidance for the year 2024. For the year, the company confirms its previously iterated guidance, expecting: Revenue to grow by low single-digit like for like, supported by strong double-digit growth in North America, while managing prices in function of input costs and market dynamics. Bekanntmachung • Apr 03
Ontex Group NV to Report Q4, 2024 Results on Feb 12, 2025 Ontex Group NV announced that they will report Q4, 2024 results on Feb 12, 2025 Bekanntmachung • Apr 02
Hygianis SPA completed the acquisition of Algerian business of Ontex Group. Hygianis SPA entered into a binding agreement to acquire Algerian business of Ontex Group on August 9, 2023. The transaction includes Ontex’s business in Algeria and related exports to certain neighboring countries. Ontex’s business in Algeria generated about €50 million sales in 2022, and is part of Ontex’s emerging markets activities, which have been classified as discontinued operations following the strategic decision in 2021 to divest these. Ontex aims to close the transaction, which is subject to customary conditions, by the end of September 2023.
Hygianis SPA completed the acquisition of Algerian business of Ontex Group on April 2, 2024. The cash proceeds prior to taxes and transaction costs are approximately €25 million and remain subject to customary post-closing adjustments. New Risk • Feb 11
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 26% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.0x net interest cover). Minor Risk Large one-off items impacting financial results. Reported Earnings • Feb 08
Full year 2023 earnings released: EPS: €0.33 (vs €1.84 loss in FY 2022) Full year 2023 results: EPS: €0.33 (up from €1.84 loss in FY 2022). Revenue: €1.79b (up 7.3% from FY 2022). Net income: €26.9m (up €175.6m from FY 2022). Profit margin: 1.5% (up from net loss in FY 2022). The move to profitability was primarily driven by higher revenue. Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Bekanntmachung • Feb 08
Ontex Group NV Provides Earnings Guidance for the Year 2024 Ontex Group NV provided earnings guidance for the year 2024. For the period, the company expects Revenue to grow by low single-digit like for like, supported by strong double-digit growth in North America, while managing prices in function of input costs and market dynamics. Bekanntmachung • Oct 27
Ontex Appoints Geert Peeters as Chief Financial Officer, Effective December 1, 2023 Ontex announces the appointment of Geert Peeters as Chief Financial Officer, effective December 1, 2023. Until recently, Geert was Group CFO at Greenyard (Euronext: GREENYARD). He built up vast experience through finance director roles at companies such as Metallo Group (currently Aurubis) and management consultancies such as PriceWaterhouseCoopers. Board Change • Oct 20
High number of new directors There are 6 new directors who have joined the board in the last 3 years. Independent Director Paul McNulty was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. New Risk • Oct 14
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Austrian stocks, typically moving 4.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.3x net interest cover). Minor Risk Share price has been volatile over the past 3 months (4.1% average weekly change). Bekanntmachung • Sep 06
Ontex Group NV Announces Change of Chief Financial Officer, Effective Early October 2023 Ontex Group NV announced that Peter Vanneste, Chief Financial Officer at Ontex, has decided to leave Ontex early October 2023, to pursue a career opportunity outside the Group. His successor will be announced in due time. In the interim the responsibilities of CFO will be assumed by Gustavo Calvo Paz, CEO. Bekanntmachung • Aug 11
Hygianis SPA entered into a binding agreement to acquire Algerian business of Ontex Group. Hygianis SPA entered into a binding agreement to acquire Algerian business of Ontex Group on August 9, 2023. The transaction includes Ontex’s business in Algeria and related exports to certain neighboring countries. Ontex’s business in Algeria generated about €50 million sales in 2022, and is part of Ontex’s emerging markets activities, which have been classified as discontinued operations following the strategic decision in 2021 to divest these. Ontex aims to close the transaction, which is subject to customary conditions, by the end of September 2023. Reported Earnings • Jul 30
First half 2023 earnings released: EPS: €0.025 (vs €1.23 loss in 1H 2022) First half 2023 results: EPS: €0.025 (up from €1.23 loss in 1H 2022). Revenue: €891.8m (up 14% from 1H 2022). Net income: €2.00m (up €101.8m from 1H 2022). Profit margin: 0.2% (up from net loss in 1H 2022). Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance. Bekanntmachung • Jul 29
Ontex Group NV, Annual General Meeting, May 08, 2024 Ontex Group NV, Annual General Meeting, May 08, 2024. Board Change • Jul 06
High number of new directors There are 6 new directors who have joined the board in the last 3 years. Independent Director Paul McNulty was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Board Change • May 20
High number of new directors There are 6 new directors who have joined the board in the last 3 years. Independent Director Paul McNulty was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Board Change • Apr 14
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. 1 highly experienced director. Independent Director Inge Boets is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Mar 06
Full year 2022 earnings released: €1.84 loss per share (vs €0.77 loss in FY 2021) Full year 2022 results: €1.84 loss per share (further deteriorated from €0.77 loss in FY 2021). Revenue: €1.67b (down 18% from FY 2021). Net loss: €148.7m (loss widened 140% from FY 2021). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 4.9% growth forecast for the Personal Products industry in Europe. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 90 percentage points per year, which is a significant difference in performance. Buying Opportunity • Mar 03
Now 22% undervalued Over the last 90 days, the stock is up 16%. The fair value is estimated to be €9.59, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.1% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to grow by 2.5% in a year. Earnings is forecast to grow by 72% in the next year. Board Change • Feb 10
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 1 experienced director. 1 highly experienced director. Independent Director Inge Boets is the most experienced director on the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Board Change • Nov 16
High number of new directors There are 7 new directors who have joined the board in the last 3 years. Independent Director Paul McNulty was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Aug 03
First half 2022 earnings released First half 2022 results: Revenue: (down 100% from 1H 2021). Net income: (down €7.20m from profit in 1H 2021). Profit margin: (down from 0.7% in 1H 2021). Over the next year, revenue is forecast to grow 1.8%, compared to a 7.7% growth forecast for the industry in Austria. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance. Board Change • Apr 28
Less than half of directors are independent There are 8 new directors who have joined the board in the last 3 years. Of these new board members, 3 were independent directors. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Director Manon Janssen was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Reported Earnings • Apr 07
Full year 2021 earnings released: €0.77 loss per share (vs €0.67 profit in FY 2020) Full year 2021 results: €0.77 loss per share (down from €0.67 profit in FY 2020). Revenue: €2.03b (down 2.9% from FY 2020). Net loss: €61.9m (down 215% from profit in FY 2020). Over the next year, revenue is forecast to grow 3.9%, compared to a 9.4% growth forecast for the industry in Austria. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 35 percentage points per year, which is a significant difference in performance. Reported Earnings • Feb 24
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: €0.77 loss per share (down from €0.67 profit in FY 2020). Revenue: €2.03b (down 2.9% from FY 2020). Net loss: €61.9m (down 215% from profit in FY 2020). Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 2.9%, compared to a 8.5% growth forecast for the industry in Austria. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 36 percentage points per year, which is a significant difference in performance. Bekanntmachung • Dec 02
Ontex Group NV Presents Its New Technology Climaflex Ontex Group NV presented its new technology Climaflex. Climaflex is the next generation baby diaper core technology developed by Ontex engineers and Ontex’s R&D team in Germany. Climaflex ensures comfort, keeps the baby’s skin protected and ensures absorption even under the toughest conditions, with extensive baby motion. The Climaflex technology is first launched under Ontex’s Little Big Change brand in six European countries1 and will be rolled out across retailer diaper brands. Key features of Climaflex technology include: Ultimateskin protection and breathability: Babies tend to sweat more than adults, but their skin is much thinner. This makes baby skin prone to rashes and irritations. The Climaflex technology enables heat to transfer across the full surface of the diaper which ensures breathability and heat regulation, keeping the baby’s skin dry and fresh; Strong liquid lock thanks to unique dual core design: Diapers with the Climaflex technology have a dual-layer core in which one layer quickly attracts liquid and a second layer locks it in a very fast way and? securely even in the toughest conditions, when the baby moves a lot; New gender-neutral channel technology: The diaper channel has been designed to deal with those areas where liquid absorption and distribution is most needed, for both baby boys and baby girls. From the central pee points onwards, liquid can quickly access, and is distributed through the branches of the channeled core which offers instant and long-lasting dryness; Exceptional freedom of movement: When learning to walk, run and play, freedom of movement is essential.? Diapers with the Climaflex technology have a lighter core and smart bending lines which offers a secure and comfortable fit even when saturated; 90 patents in 38 countries – rollout across geographies and categories: Ontex has more than 90 granted and pending patents protecting the innovations that are incorporated in Climaflex, covering more than 38 countries including the US, Belgium, France, Germany, Great Britain, Italy, the Netherlands, Spain and Turkey. In addition, Ontex has 12 registered designs protecting ornamental aspects of the Climaflex proposition. These patents join Ontex’s large and growing patent portfolio that protects many product features which enhance dryness, comfort and absorption, such as instant dryness technology SeconDRY and channel technology for faster absorption. Several technologies are also rolled out across Ontex’s adult care and feminine care categories, like channel technology in adult incontinence pants. Ontex’s scale allows innovations to be rolled out across geographies, while taking local product innovation and preferences into account. Recent innovation examples include Ontex’s smart incontinence solution Orizon, instant dryness technology SeconDRY, and the successful introduction of more natural components in its diapers. Reported Earnings • Jul 30
First half 2021 earnings released: EPS €0.09 (vs €0.51 in 1H 2020) The company reported a poor first half result with weaker earnings, revenues and profit margins. First half 2021 results: Revenue: €980.6m (down 6.9% from 1H 2020). Net income: €7.20m (down 83% from 1H 2020). Profit margin: 0.7% (down from 3.9% in 1H 2020). Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 29% per year, which means it has not declined as severely as earnings. Bekanntmachung • Jun 22
Ontex May Reportedly Divest Branch Ontex Group NV (ENXTBR:ONTEX) is reportedly considering divesting its Brazilian branch as part of its strategic review. The Company is expected to provide more information on the matter later. Bekanntmachung • Jun 17
Ontex Launches Smart Diaper Service That Enhances Continence Care Efficiency and Dignity Ontex has developed a smart continence management service to care homes and hospitals in Europe under the brand Orizon. Hospitals and elderly care facilities face tremendous time and budget pressure to take care of residents. Incontinence is one of the most prevalent conditions in age care facilities, and one of the most important components of the cost for caring in institutions. Around 80% of care home residents have some form of incontinence, as shown in Ontex order data from care homes. The Orizon solution contains a printed sensor, a transmitter clipped onto the diaper, as well as a mobile and web application. This combination accurately determines the saturation level of the diaper and alerts caregivers when it is possibly necessary to change the diaper. Launch in Europe: Ontex is going to run pilot projects of Orizon in Belgium, France, Germany, Italy and the UK, with a commercial launch across Europe later 2021. During a first field study at the start of Orizon’s ongoing validation process, Orizon was tested at care home De Dennen in Malle, Belgium. Common condition in aging population: Incontinence is a very common condition, especially with elderly people in hospitals and care homes. According to research done by the World Health Organization, between 10 and 36% of people over the age of 60 are affected by incontinence and use incontinence products. Even if incontinence is most common among the elderly, it affects all ages of the population. The group of people over 60 years of age is expected to rise from nearly 1 billion worldwide now to nearly 2.1 billion by 2050, further straining healthcare systems around the world. Orizon aims to reinvent continence care together with caregivers to make caregiving easier and more manageable as the population ages worldwide, especially in Europe and large parts of Asia. New brand and model: Unlike most of Ontex’s existing incontinence brands and services, Orizon is based on a monthly fee. By launching Orizon, Ontex aims to optimize the total continence management cost by reducing waste, laundry cost and staff time spent on continence care. Incontinence care is optimized due to a more tailored, individual incontinence care for residents. This results in an optimal use of the absorbent capacity, reducing total consumption, and more time for staff to spend on other care tasks or quality time. Orizon will be brought to the market by Ontex’s two leading incontinence brands, Serenity and iD, capitalizing on existing brand awareness and reputation in European hospitals and care homes. Bekanntmachung • Apr 29
Ontex Group NV Provides Revenue Guidance for the Year 2021 Ontex Group NV provided revenue guidance for the year 2021. For the year, the company expects to have stable LFL revenue in 2021 with growth starting in Q2. Reported Earnings • Apr 26
Full year 2020 earnings released: EPS €0.67 (vs €0.46 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: €2.09b (down 8.5% from FY 2019). Net income: €54.0m (up 45% from FY 2019). Profit margin: 2.6% (up from 1.6% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings. Reported Earnings • Feb 25
Full year 2020 earnings released: EPS €0.67 (vs €0.46 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: €2.09b (down 8.5% from FY 2019). Net income: €54.0m (up 45% from FY 2019). Profit margin: 2.6% (up from 1.6% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 27% per year, which means it has not declined as severely as earnings. Analyst Estimate Surprise Post Earnings • Feb 25
Revenue misses expectations Revenue missed analyst estimates by 0.8%. Over the next year, revenue is forecast to stay flat compared to a 5.4% growth forecast for the Personal Products industry in Austria. Is New 90 Day High Low • Feb 23
New 90-day low: €9.08 The company is down 10.0% from its price of €10.09 on 24 November 2020. The Austrian market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is down 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €24.76 per share. Bekanntmachung • Feb 18
Ontex Develops New Smart Diaper Solution for Incontinence Ontex has developed a smart solution to improve incontinence care for patients, accelerating innovation in adult care, a category that has seen good and steady growth in recent years. Ontex’s innovative solution comprises a top-quality diaper with a printed sensor, a transmitter clipped onto the diaper as well as an application for mobile devices. This combination accurately determines the saturation level of the diaper as well as the risk of leakage and alerts caregivers when it is necessary to change the diaper. This enables tailored, individual continence support for patients which contributes to the well-being of users, families and caregivers alike. The smart diaper also reduces the environmental impact of care institutions by decreasing unnecessary diaper usage and allowing savings on laundry. Ontex’s new smart diaper has successfully passed the first stage of its validation after six weeks of testing in normal conditions of use at a senior care facility in Belgium. Results show the potential to reduce cases of urine leaks on clothes and linen by up to 50%, therefore alleviating one of the most burdensome and costly tasks in institutions. The validation process will continue during the first half of 2021, with a gradual commercial launch in the second quarter of this year. Incontinence is a very common condition. Almost one in ten persons in Belgium already suffers or will at some time suffer from some form of incontinence (defined1 as involuntary emission of faeces or urine, and loss of bladder or sphincter control). Even if incontinence is most common among the elderly, it affects all ages of the population. Incontinence is perceived as an embarrassing condition and finding the right support and personal hygiene product can be a challenge for people suffering from it. Is New 90 Day High Low • Jan 26
New 90-day low: €9.12 The company is down 8.0% from its price of €9.90 on 27 October 2020. The Austrian market is up 37% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €12.50 per share. Bekanntmachung • Dec 23
Ontex Group Announces Management Changes Ontex Group NV has appointed Mrs. Esther Berrozpe Galindo as new Chief Executive Officer, with effect from January 1, 2021. On that date, Mrs. Berrozpe will succeed Mr. Thierry Navarre, who has been acting as interim CEO since July 30, 2020. To ensure a smooth transition, Mr. Navarre will remain at Ontex until March 31, 2021. During her long career at Whirlpool, Mrs. Berrozpe led different business units in North America, Europe, the Middle East and Africa, driving business turnaround, improving Whirlpool’s competitiveness and strengthening its leadership position in these regions. In the last two years she has held board positions in various leading enterprises in a variety of industries, including Ontex, from which she has resigned. Mrs. Berrozpe started her professional career in FMCG, holding marketing and commercial roles at Paglieri, Sara Lee and Wella. Bekanntmachung • Nov 04
Ontex Group NV, Annual General Meeting, May 25, 2021 Ontex Group NV, Annual General Meeting, May 25, 2021. Is New 90 Day High Low • Oct 29
New 90-day low: €9.90 The company is down 19% from its price of €12.28 on 30 July 2020. The Austrian market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is down 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €21.66 per share. Bekanntmachung • Oct 13
Ontex Announces Board and Governance Changes Ontex announced changes to its Board of Directors and the creation of a Strategy Committee as the company continues to sharpen its strategic focus. Ontex announces that Gunnar Johansson has decided to step down from the Board of Directors after serving for more than six years as a director and as chair of the remuneration and nomination committee (RNC) for five years. Mrs. Esther Berrozpe, independent director, will act as chair of the RNC going forward. The Board of Directors has decided to co-opt Mr. Frédéric Larmuseau as an independent non-executive director and submit his appointment for ratification at the next shareholders meeting. Mr. Larmuseau brings to Ontex his extensive experience of the consumer goods sector and a broad international outlook. He was until recently CEO of Jacobs Douwe Egberts, the Dutch coffee and tea company that recently listed on Euronext Amsterdam under the name JDE Peet’s Group. Prior to that, he worked in several senior management positions in the Americas, Asia and the Middle East for nearly 17 years at Reckitt Benckiser, following 7 years at Procter & Gamble. The Board of Directors has also decided to create within the Board a Strategy Committee that will be tasked with advising the Board with respect to the company’s medium- and long-term strategy and oversee the disciplined execution of strategic projects. The Strategy Committee will further sharpen the Company’s focus on strategic opportunities and expedite the Board’s strategic decision-making in a rapidly-evolving environment. The Committee will be chaired by the Chairman of the Board. Is New 90 Day High Low • Sep 26
New 90-day low: €11.01 The company is down 15% from its price of €12.92 on 26 June 2020. The Austrian market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is down 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €16.55 per share. Bekanntmachung • Sep 19
Ontex Group Reportedly Considers Bid for Domtar Personal Care Unit Ontex Group NV (ENXTBR:ONTEX) is considering a bid for Domtar Corporation (NYSE:UFS)’s personal-care business that could value the unit at as much as $1.1 billion, according to people with knowledge of the matter. Ontex is working with an adviser to prepare a bid for the business, which Domtar announced was under review in August, said the people who asked not to be identified because the matter is private. Ontex could work with a partner to help fund the transaction, the people said. The unit, which is generating about $110 million in annual earnings before interest, taxes, depreciation, and amortization, is also attracting private equity interest, the people said. No final decision has been made and Domtar could elect to keep business. A representative for Ontex declined to comment. A representative for Domtar didn’t respond to requests for comment. Bekanntmachung • Jul 31
Ontex Group NV Announces Management Changes Ontex Group NV (Ontex or the Company) disclosed that Charles Bouaziz is stepping down from his role of Chief Executive Officer of Ontex, with effect from July 30, 2020. Thierry Navarre has been appointed Chief Executive Officer ad interim. Thierry Navarre has been on Ontex’s Executive Leadership Team since 2009 when he was appointed Chief Operating Officer, and became Chief Transformation Officer in 2019. Previously, he was the Group Supply Chain Director and has worked within Ontex for almost 15 years. The Board of Directors has commissioned an executive search firm to coordinate the process of identifying a permanent Chief Executive Officer among internal and external candidates. The Board of Directors thanks Charles Bouaziz for his contribution over the past seven and a half years, during which the Company developed from a European-focused private label manufacturer to a publicly-listed global personal hygiene player with an extensive portfolio of Retail Brands and Own Brands. 
